Theodore Robertson Pak, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shock, Septic | 3 | 2024 | 768 | 1.230 |
Why?
|
Sepsis | 3 | 2024 | 2585 | 1.000 |
Why?
|
Cross Infection | 6 | 2024 | 1421 | 0.740 |
Why?
|
Meta-Analysis as Topic | 2 | 2016 | 1377 | 0.720 |
Why?
|
Communicable Diseases | 2 | 2016 | 875 | 0.570 |
Why?
|
Genomics | 5 | 2021 | 5820 | 0.550 |
Why?
|
Hospital Mortality | 3 | 2024 | 5291 | 0.530 |
Why?
|
Genome, Bacterial | 4 | 2020 | 783 | 0.520 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2015 | 18 | 0.510 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4741 | 0.500 |
Why?
|
Disease Management | 2 | 2016 | 2507 | 0.480 |
Why?
|
Computational Biology | 2 | 2016 | 3517 | 0.440 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2015 | 237 | 0.440 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3639 | 0.430 |
Why?
|
Quinolones | 1 | 2015 | 378 | 0.400 |
Why?
|
Clostridium Infections | 2 | 2019 | 558 | 0.390 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7409 | 0.380 |
Why?
|
Molecular Epidemiology | 2 | 2020 | 469 | 0.300 |
Why?
|
Bacteremia | 4 | 2020 | 978 | 0.250 |
Why?
|
Length of Stay | 2 | 2024 | 6422 | 0.250 |
Why?
|
Health Care Costs | 1 | 2017 | 3243 | 0.230 |
Why?
|
Propensity Score | 2 | 2024 | 1908 | 0.220 |
Why?
|
Electronic Health Records | 2 | 2017 | 4811 | 0.210 |
Why?
|
Disease Outbreaks | 3 | 2021 | 1749 | 0.200 |
Why?
|
Software | 2 | 2015 | 4434 | 0.200 |
Why?
|
England | 1 | 2023 | 527 | 0.200 |
Why?
|
Staphylococcal Infections | 3 | 2020 | 1407 | 0.200 |
Why?
|
Morphine | 1 | 2005 | 656 | 0.190 |
Why?
|
DNA Modification Methylases | 1 | 2019 | 210 | 0.160 |
Why?
|
Chikungunya virus | 1 | 2018 | 56 | 0.150 |
Why?
|
Daptomycin | 1 | 2018 | 71 | 0.150 |
Why?
|
Enterococcus faecium | 1 | 2018 | 101 | 0.140 |
Why?
|
Hospitals | 4 | 2023 | 3882 | 0.140 |
Why?
|
Nitric Oxide | 1 | 2005 | 2133 | 0.140 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2020 | 697 | 0.140 |
Why?
|
Word Processing | 1 | 2015 | 7 | 0.120 |
Why?
|
New York | 1 | 2017 | 874 | 0.120 |
Why?
|
Vancomycin | 1 | 2018 | 503 | 0.120 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2018 | 587 | 0.120 |
Why?
|
Massachusetts | 2 | 2024 | 8832 | 0.120 |
Why?
|
DNA, Bacterial | 2 | 2019 | 1479 | 0.120 |
Why?
|
Genes, Bacterial | 1 | 2017 | 1073 | 0.110 |
Why?
|
Oncogenic Viruses | 1 | 2012 | 37 | 0.100 |
Why?
|
Microbial Sensitivity Tests | 2 | 2018 | 1937 | 0.100 |
Why?
|
Amyloid beta-Peptides | 1 | 2005 | 3837 | 0.100 |
Why?
|
Yeasts | 1 | 2012 | 279 | 0.100 |
Why?
|
Internet | 2 | 2015 | 3092 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 370 | 0.090 |
Why?
|
Sex Factors | 1 | 2024 | 10548 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2024 | 80582 | 0.090 |
Why?
|
Influenza, Human | 1 | 2021 | 1521 | 0.090 |
Why?
|
Humans | 21 | 2024 | 761423 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1458 | 0.090 |
Why?
|
Workflow | 1 | 2015 | 851 | 0.080 |
Why?
|
Genome, Human | 2 | 2012 | 4425 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 819 | 0.080 |
Why?
|
Trans-Activators | 1 | 2018 | 2856 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3357 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 2019 | 3846 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2015 | 1400 | 0.080 |
Why?
|
Phylogeny | 3 | 2020 | 2811 | 0.070 |
Why?
|
Tissue Donors | 1 | 2017 | 2331 | 0.070 |
Why?
|
Minisatellite Repeats | 1 | 2007 | 164 | 0.070 |
Why?
|
Adult | 6 | 2024 | 221148 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3061 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3798 | 0.070 |
Why?
|
Microsatellite Repeats | 1 | 2007 | 785 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2017 | 2333 | 0.060 |
Why?
|
Viral Proteins | 1 | 2012 | 1803 | 0.060 |
Why?
|
Aged | 6 | 2024 | 169235 | 0.060 |
Why?
|
Alzheimer Disease | 1 | 2005 | 8596 | 0.060 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2005 | 311 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1458 | 0.060 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2019 | 1133 | 0.050 |
Why?
|
Logistic Models | 1 | 2017 | 13255 | 0.050 |
Why?
|
Time Factors | 1 | 2023 | 39975 | 0.050 |
Why?
|
Endopeptidases | 1 | 2005 | 773 | 0.050 |
Why?
|
Cohort Studies | 1 | 2024 | 41446 | 0.050 |
Why?
|
Middle Aged | 5 | 2024 | 220826 | 0.050 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2005 | 620 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 1171 | 0.050 |
Why?
|
Spores, Bacterial | 1 | 2019 | 113 | 0.040 |
Why?
|
Genetic Variation | 2 | 2019 | 6581 | 0.040 |
Why?
|
Male | 6 | 2024 | 360736 | 0.040 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2019 | 183 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4575 | 0.040 |
Why?
|
Culicidae | 1 | 2018 | 108 | 0.040 |
Why?
|
Mutation | 3 | 2019 | 30045 | 0.040 |
Why?
|
Female | 6 | 2024 | 392581 | 0.040 |
Why?
|
Vancomycin Resistance | 1 | 2018 | 125 | 0.040 |
Why?
|
Cricetinae | 1 | 2019 | 2425 | 0.030 |
Why?
|
Adolescent | 3 | 2020 | 88313 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1791 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2018 | 559 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 59207 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1302 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 559 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2019 | 844 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2017 | 58956 | 0.030 |
Why?
|
Polyomavirus | 1 | 2012 | 234 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1843 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2012 | 460 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2024 | 3744 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2020 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2005 | 12796 | 0.020 |
Why?
|
Cell Lineage | 1 | 2018 | 2555 | 0.020 |
Why?
|
Monocytes | 1 | 2018 | 2572 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2012 | 815 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16979 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2019 | 26212 | 0.020 |
Why?
|
Documentation | 1 | 2015 | 897 | 0.020 |
Why?
|
Adenoviridae | 1 | 2012 | 1084 | 0.020 |
Why?
|
Heredodegenerative Disorders, Nervous System | 1 | 2007 | 16 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6309 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 743 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2018 | 2746 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36205 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1079 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2012 | 1119 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4391 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2007 | 492 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 13009 | 0.020 |
Why?
|
Animals | 4 | 2019 | 168441 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10718 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5428 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7392 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22164 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3595 | 0.010 |
Why?
|
Mice | 2 | 2019 | 81509 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11902 | 0.010 |
Why?
|
Models, Genetic | 1 | 2007 | 3446 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2007 | 2687 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9418 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8545 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42254 | 0.010 |
Why?
|
Child | 1 | 2018 | 80162 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23441 | 0.010 |
Why?
|